← Open Payments lookup

ANN PARKER: Open Payments

NPI 1588965784 · BOWIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$386 in 15 payments from 9 companies in 2025. Trend: 2023 $678 · 2024 $395 · 2025 $386

Food & beverage: $386
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$95
Mallinckrodt Hospital Products Inc.2$62
Merck Sharp & Dohme LLC2$54
Veloxis Pharmaceuticals, Inc.2$48
Astellas Pharma US Inc1$30
ABBVIE INC.1$30
Intercept Pharmaceuticals, Inc.1$25
Gilead Sciences, Inc.1$23
Novo Nordisk Inc1$19

Products named: XIFAXAN, TERLIVAZ, PREVYMIS, ENVARSUS, Cresemba, MAVYRET, OCALIVA, Wegovy.

Industry payments across MD — which companies pay providers there.